您的当前位置:首页 > 行业数据 > 重组抗BDCA2人源化单克隆抗体注射液(626)研究进展
图片属性
图片格式:PNG 图片大小:114KB 图片尺寸:2245*442
同报告图片
 / 4
重组抗BDCA2人源化单克隆抗体注射液(626)研究进展_第1页
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
重组抗BDCA2人源化单克隆抗体注射液(626)研究进展_第2页
fCDlubTku70gfCDmgqPnl4XkurrmlbDvvIjljYPkurrvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS18CnwgMjAyM0UgfCA2MTAwIHwKfCAyMDI0RSB8IDYxMDAgfAp8IDIwMjVFIHwgNjIwMCB8CnwgMjAyNkUgfCA2MzAwIHwKfCAyMDI3RSB8IDY0MDAgfAp8IDIwMjhFIHwgNjUwMCB8CnwgMjAyOUUgfCA2NjAwIHwKfCAyMDMwRSB8IDY3MDAgfAoK6LWE5paZ5p2l5rqQ77ya5rKZ5Yip5paH77yM5Lit5Y2O5Yy75a2m5Lya6aOO5rm/55eF5a2m5YiG5Lya77yM5LiJ55Sf5Zu95YGl5oub6IKh6K+05piO5Lmm77yM5Lic5pa56LSi5a+M6K+B5Yi456CU56m25omA
重组抗BDCA2人源化单克隆抗体注射液(626)研究进展_第3页
重组抗BDCA2人源化单克隆抗体注射液(626)研究进展_第4页
重组抗BDCA2人源化单克隆抗体注射液(626)研究进展_第5页
所属报告: 三生国健-公司深度研究:自免项目顺利推进多个品种开花结果-250620(42页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠